Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism PDGFRα inhibitors(Platelet-derived growth factor receptor alpha inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | TW | 30 May 2018 |